Natco Pharma gains 4% on emergency use approval for Covid-19 medicine ...Middle East

The company has received Emergency Use approval for Baricitinib tablets, 1mg, 2mg and 4mg strengths from Central Drugs Standard Control Organization (CDSCO) in India

Hence then, the article about natco pharma gains 4 on emergency use approval for covid 19 medicine was published today ( Monday 03/05/2021 - 09:00 AM ) and is available on Business Standard ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Natco Pharma gains 4% on emergency use approval for Covid-19 medicine )

Also on site :

• Kenya: 1 in 2 Kenyans Report Economy-Related Stress As 1 in 4 Suffer Mental Breakdown
• Gambia: Govt Yet to Confirm Reported Tragic Deaths of 190 Migrants - Trade Minister
• South Korean Company Signs $4 Billion Arms Deal with Poland